12/11/2025 16:00
3Degrees Welcomes David Dines to Board of Directors

3Degrees, a global leader in renewable energy and climate solutions, is pleased to announce the appointment of David Dines to its Board of Directors, effective December 8, 2025. Dines brings more than four decades of leadership experience across global energy, commodities, financial services, transportation, and industrial markets. He served on the executive team as Chief Financial Officer and Corporate Senior Vice President at Cargill, Inc., the largest privately held company in the United St...

Correspondent - Berlin

Correspondent - Berlin

Starting date: September 1, 2025
Deadline for applications: July 25, 2025
Location: Berlin, Germany - Europe region
 

THE JOB


AFP is seeking a dynamic and motivated native-level English-speaking correspondent to join its reporting team in Berlin, Germany.

AFP wins top fact-checking award at Global Fact 12

AFP took home the prestigious Gold Standard award at Global Fact 12, the world’s largest summit dedicated to fact-checking, for a months-long investigation on a coordinated network spreading disinformation about the South China Sea.

AFP took home the prestigious Gold Standard award at Global Fact 12, the world’s largest summit dedicated to fact-checking, for a months-long investigation on a coordinated network spreading disinformation about the South China Sea.
12/15/2025 09:00
GENESIS Pharma announces a new partnership with Otsuka Pharmaceutical Europe Ltd. for the commercialization of donidalorsen for hereditary angioedema in Central and Eastern Europe

  ANNOUNCEMENT FOR EUROPEAN MEDICAL & PHARMACEUTICAL TRADE MEDIA AND EUROPEAN FINANCIAL MEDIA ONLY GENESIS Pharma, a regional biopharma company focused on the commercialization of innovative medicines in Central and Eastern Europe, announces an exclusive agreement with Otsuka Pharmaceutical Europe Ltd. (OPEL), the European operation of global healthcare company Otsuka Pharmaceutical Co., Ltd., for donidalorsen. Under the terms of the agreement, GENESIS Pharma will exclusively distribute a...

Subscribe to